{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:12:20Z","timestamp":1774260740881,"version":"3.50.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ministry of Science and Technology of China","award":["2016YFA0502303"],"award-info":[{"award-number":["2016YFA0502303"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22033001"],"award-info":[{"award-number":["22033001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21633001"],"award-info":[{"award-number":["21633001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The COVID-19 pandemic calls for rapid development of effective treatments. Although various drug repurpose approaches have been used to screen the FDA-approved drugs and drug candidates in clinical phases against SARS-CoV-2, the coronavirus that causes this disease, no magic bullets have been found until now. In this study, we used directed message passing neural network to first build a broad-spectrum anti-beta-coronavirus compound prediction model, which gave satisfactory predictions on newly reported active compounds against SARS-CoV-2. Then, we applied transfer learning to fine-tune the model with the recently reported anti-SARS-CoV-2 compounds and derived a SARS-CoV-2 specific prediction model COVIDVS-3. We used COVIDVS-3 to screen a large compound library with 4.9 million drug-like molecules from ZINC15 database and recommended a list of potential anti-SARS-CoV-2 compounds for further experimental testing. As a proof-of-concept, we experimentally tested seven high-scored compounds that also demonstrated good binding strength in docking studies against the 3C-like protease of SARS-CoV-2 and found one novel compound that can inhibit the enzyme. Our model is highly efficient and can be used to screen large compound databases with millions or more compounds to accelerate the drug discovery process for the treatment of COVID-19.<\/jats:p>","DOI":"10.1093\/bib\/bbab211","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T15:11:25Z","timestamp":1621005085000},"source":"Crossref","is-referenced-by-count":43,"title":["A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2"],"prefix":"10.1093","volume":"22","author":[{"given":"Shiwei","family":"Wang","sequence":"first","affiliation":[{"name":"Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjun","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Pei","sequence":"additional","affiliation":[{"name":"Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luhua","family":"Lai","sequence":"additional","affiliation":[{"name":"College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"2021110815063213100_ref1","volume-title":"WHO Coronavirus Disease (COVID-19) Dashboard","author":"World Health Organization"},{"issue":"8","key":"2021110815063213100_ref2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"7798","key":"2021110815063213100_ref3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"5","key":"2021110815063213100_ref4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"7798","key":"2021110815063213100_ref5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"13","key":"2021110815063213100_ref6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"2021110815063213100_ref7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"issue":"1","key":"2021110815063213100_ref8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"2021110815063213100_ref9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"2021110815063213100_ref10","doi-asserted-by":"crossref","first-page":"e00819","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"21","key":"2021110815063213100_ref11","doi-asserted-by":"crossref","first-page":"e01218","DOI":"10.1128\/JVI.01218-20","article-title":"Broad anti-coronavirus activity of Food and Drug Administration-approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo","volume":"94","author":"Weston","year":"2020","journal-title":"J Virol"},{"issue":"1","key":"2021110815063213100_ref12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci Rep"},{"issue":"10","key":"2021110815063213100_ref13","doi-asserted-by":"crossref","first-page":"e00825","DOI":"10.1128\/AAC.00825-20","article-title":"Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and proinflammatory cytokine production","volume":"64","author":"Fintelman-Rodrigues","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2021110815063213100_ref14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.06.026476","article-title":"Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro","author":"Yamamoto","year":"2020","journal-title":"bio Rxiv"},{"issue":"9","key":"2021110815063213100_ref15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"H-x","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2021110815063213100_ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/14756366.2021.1873977","article-title":"Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro","volume":"36","author":"Liu","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2021110815063213100_ref17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"4","key":"2021110815063213100_ref18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"issue":"8","key":"2021110815063213100_ref19","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000028","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 13 Billion compounds","volume":"39","author":"Ton","year":"2020","journal-title":"Mol Inform"},{"issue":"4","key":"2021110815063213100_ref20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat Med"},{"issue":"11","key":"2021110815063213100_ref21","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15--ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J Chem Inf Model"},{"issue":"4","key":"2021110815063213100_ref22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.drudis.2020.01.015","article-title":"Recent discovery and development of inhibitors targeting coronaviruses","volume":"25","author":"Pillaiyar","year":"2020","journal-title":"Drug Discov Today"},{"issue":"12","key":"2021110815063213100_ref23","doi-asserted-by":"crossref","first-page":"e00023","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J Virol"},{"issue":"8","key":"2021110815063213100_ref24","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of middle east respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2021110815063213100_ref25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/v13040651","article-title":"Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19","volume":"13","author":"Ko","year":"2021","journal-title":"Viruses"},{"issue":"12","key":"2021110815063213100_ref26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/v10120721","article-title":"Development of small-molecule MERS-CoV inhibitors","volume":"10","author":"Liang","year":"2018","journal-title":"Viruses"},{"issue":"6","key":"2021110815063213100_ref27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/v10060283","article-title":"Saracatinib inhibits middle east respiratory syndrome-coronavirus replication in vitro","volume":"10","author":"Shin","year":"2018","journal-title":"Viruses"},{"issue":"7827","key":"2021110815063213100_ref28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"issue":"42","key":"2021110815063213100_ref29","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1810137115","article-title":"The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis","volume":"115","author":"Janes","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"2021110815063213100_ref30","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","article-title":"Analyzing learned molecular representations for property prediction","volume":"59","author":"Yang","year":"2019","journal-title":"J Chem Inf Model"},{"key":"2021110815063213100_ref31","first-page":"1263","volume-title":"Proceedings of the 34th International Conference on Machine Learning, P. Doina and T. Yee Whye (eds) 2017","author":"Gilmer"},{"issue":"1","key":"2021110815063213100_ref32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0169-7439(97)00061-0","article-title":"Introduction to multi-layer feed-forward neural networks","volume":"39","author":"Svozil","year":"1997","journal-title":"Chemom Intell Lab Syst"},{"key":"2021110815063213100_ref33","volume-title":"International Workshop on Multiple Classifier Systems","author":"Dietterich","year":"2000"},{"issue":"10","key":"2021110815063213100_ref34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1109\/TKDE.2009.191","article-title":"A survey on transfer learning","volume":"22","author":"Pan","year":"2010","journal-title":"IEEE Trans Knowl Data Eng"},{"issue":"1\u20132","key":"2021110815063213100_ref35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11263-013-0693-1","article-title":"Domain adaptation for face recognition: targetize source domain bridged by common subspace","volume":"109","author":"Kan","year":"2014","journal-title":"Int J Comput Vis"},{"key":"2021110815063213100_ref36","doi-asserted-by":"crossref","DOI":"10.3115\/1687878.1687914","article-title":"A non-negative matrix tri-factorization approach to sentiment classification with lexical prior knowledge","volume-title":"Proceedings of the Joint Conference of the 47th Annual Meeting of the ACL and the 4th International Joint Conference on Natural Language Processing of the AFNLP: Volume 1 - Volume 1","author":"Li","year":"2009"},{"key":"2021110815063213100_ref37","doi-asserted-by":"crossref","DOI":"10.1145\/1281192.1281218","article-title":"Co-clustering based classification for out-of-domain documents","volume-title":"Proceedings of the 13th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","author":"Dai","year":"2007"},{"issue":"18","key":"2021110815063213100_ref38","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem Rev"},{"issue":"16","key":"2021110815063213100_ref39","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1021\/acs.jmedchem.9b02147","article-title":"Transfer learning for drug discovery","volume":"63","author":"Cai","year":"2020","journal-title":"J Med Chem"},{"key":"2021110815063213100_ref40","article-title":"RDKit: open-source cheminformatics"},{"key":"2021110815063213100_ref41","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res"},{"issue":"3","key":"2021110815063213100_ref42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"2021110815063213100_ref43","first-page":"226","volume-title":"Proceedings of the 2nd International Conference on Knowledge Discovery and Data Mining, Portland, OR, AAAI Press","author":"Ester","year":"1996"},{"issue":"3","key":"2021110815063213100_ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3068335","article-title":"DBSCAN revisited, revisited: why and how you should (still) use DBSCAN","volume":"42","author":"Schubert","year":"2017","journal-title":"ACM Trans Database Syst"},{"issue":"13","key":"2021110815063213100_ref45","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J"},{"issue":"2","key":"2021110815063213100_ref46","first-page":"455","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"16","key":"2021110815063213100_ref47","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"2021110815063213100_ref48","volume-title":"PubChem Bioassay Record for AID 1706, Source: The Scripps Research Institute Molecular Screening Center","author":"National Center for Biotechnology Information"},{"issue":"5","key":"2021110815063213100_ref49","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"2021110815063213100_ref50","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1360\/SSC-2020-0145","article-title":"Advances in enzymatic activity regulation mechanism and inhibitor discovery of Coronavirus 3C-like protease","volume":"50","author":"Li","year":"2020","journal-title":"Sci Sin Chim"},{"key":"2021110815063213100_ref51","doi-asserted-by":"crossref","first-page":"112711","DOI":"10.1016\/j.ejmech.2020.112711","article-title":"The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020","volume":"206","author":"Liu","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2021110815063213100_ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"2021110815063213100_ref53","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/bib\/bbaa422","article-title":"Ligand-based approach for predicting drug targets and for virtual screening against COVID-19","volume":"22","author":"Yang","year":"2021","journal-title":"Brief Bioinform"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab211\/41087960\/bbab211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab211\/41087960\/bbab211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T10:09:20Z","timestamp":1636366160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab211\/6291517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab211","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.28.271569","asserted-by":"object"}]},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,6,3]]},"article-number":"bbab211"}}